マーケットレポート詳細
肺投与型ドラッグデリバリーシステムの世界市場：2031年予測
Pulmonary Drug Delivery Devices Market (Product Type: Dry Powder Inhalers, Metered Dose Inhalers, and Nebulizers; Application: Asthma, COPD, and Cystic Fibrosis) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
- 出版元：Transparency Market Research
出版元について - 発行年：2023年11月
- 定価 ：Single User License(1名様ライセンス)US$5,795(米国ドル)/Multi User License(5名様)$8,795 /Enterprise License $11,705
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文170ページになります。
- 商品コード：TMR110
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
肺投与型ドラッグデリバリーシステムの世界市場規模は2022年で372億ドル、2031年に550億ドル、市場の平均年成長率は4.4%になる見込みです。
当レポートでは、肺投与型ドラッグデリバリーシステムの市場予測-2031年、各種セグメント別市場分析(製品タイプ別、用途別、国地域別、等)、パイプライン分析、COVID-19の影響分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。
【レポート構成概要】
■肺投与型ドラッグデリバリーシステムの世界市場予測2023-2031年
・市場規模(US$)
・台数(Units)
■製品タイプ別、市場-2031年
乾燥粉末吸入器
定量吸入器
ネブライザー
※(市場規模US$) (台数Units)
■用途別、市場-2031年
喘息
慢性閉塞性肺疾患（COPD）
嚢胞性線維症
※(市場規模US$)
■販売経路別、市場-2031年
小売薬局
病院薬局
eコマース
※(市場規模US$)
■主要国地域別市場-2031年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
南米
・ブラジル、メキシコ
・その他南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照
■市場分析
市場ダイナミクス（促進要因、障壁、機会）
パイプライン分析
COVID-19の影響分析
競合状況
市場シェア分析
■肺投与型ドラッグデリバリーシステムの主要企業プロフィール動向
AstraZeneca Plc
Novartis AG
Boehringer Ingelheim GmbH
GlaxoSmithKline Plc
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
（全170頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1. Executive Summary
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Pulmonary Drug Delivery Devices Market
4. Market Overview
4.1. Market Segmentation
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, 2023-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Disease Prevalence & Incidence Rate Globally With Key Countries
5.3. COVID-19 Pandemic Impact on Industry
6. Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Product Type
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value & Volume Forecast, by Product Type, 2023-2031
6.3.1. Dry Powder Inhalers
6.3.2. Metered Dose Inhalers
6.3.3. Nebulizers
6.4. Market Attractiveness, by Product Type
7. Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Application
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value & Volume Forecast, by Application, 2023-2031
7.3.1. Asthma
7.3.2. COPD
7.3.3. Cystic Fibrosis
7.3.4. Others
7.4. Market Attractiveness, by Application
8. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Distribution Channel
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
8.3.1. Retail Pharmacies
8.3.2. Hospital Pharmacies
8.3.3. E-Commerce
8.4. Market Attractiveness, by Distribution Channel
9. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value & Volume Forecast, by Region, 2023-2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Region
10. North America Pulmonary Drug Delivery Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Product Type, 2023-2031
10.2.1. Dry Powder Inhalers
10.2.2. Metered Dose Inhalers
10.2.3. Nebulizers
10.3. Market Attractiveness, by Product Type
10.4. Market Value & Volume Forecast, by Application, 2023-2031
10.4.1. Asthma
10.4.2. COPD
10.4.3. Cystic Fibrosis
10.4.4. Others
10.5. Market Attractiveness, by Application
10.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
10.6.1. Retail Pharmacies
10.6.2. Hospital Pharmacies
10.6.3. E-Commerce
10.7. Market Attractiveness, by Distribution Channel
10.8. Market Value & Volume Forecast, by Country, 2023-2031
10.8.1. U.S.
10.8.2. Canada
10.9. Market Attractiveness Analysis
10.9.1. By Product Type
10.9.2. By Application
10.9.3. By Distribution Channel
10.9.4. By Country
11. Europe Pulmonary Drug Delivery Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Product Type, 2023-2031
11.2.1. Dry Powder Inhalers
11.2.2. Metered Dose Inhalers
11.2.3. Nebulizers
11.3. Market Attractiveness, by Product Type
11.4. Market Value & Volume Forecast, by Application, 2023-2031
11.4.1. Asthma
11.4.2. COPD
11.4.3. Cystic Fibrosis
11.4.4. Others
11.5. Market Attractiveness, by Application
11.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
11.6.1. Retail Pharmacies
11.6.2. Hospital Pharmacies
11.6.3. E-Commerce
11.7. Market Attractiveness, by Distribution Channel
11.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031
11.8.1. Germany
11.8.2. U.K.
11.8.3. France
11.8.4. Italy
11.8.5. Spain
11.8.6. Rest of Europe
11.9. Market Attractiveness Analysis
11.9.1. By Product Type
11.9.2. By Application
11.9.3. By Distribution Channel
11.9.4. By Country/Sub-region
12. Asia Pacific Pulmonary Drug Delivery Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Product Type, 2023-2031
12.2.1. Dry Powder Inhalers
12.2.2. Metered Dose Inhalers
12.2.3. Nebulizers
12.3. Market Attractiveness, by Product Type
12.4. Market Value & Volume Forecast, by Application, 2023-2031
12.4.1. Asthma
12.4.2. COPD
12.4.3. Cystic Fibrosis
12.4.4. Others
12.5. Market Attractiveness, by Application
12.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
12.6.1. Retail Pharmacies
12.6.2. Hospital Pharmacies
12.6.3. E-Commerce
12.7. Market Attractiveness, by Distribution Channel
12.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031
12.8.1. China
12.8.2. Japan
12.8.3. India
12.8.4. Australia & New Zealand
12.8.5. Rest of Asia Pacific
12.9. Market Attractiveness Analysis
12.9.1. By Product Type
12.9.2. By Application
12.9.3. By Distribution Channel
12.9.4. By Country/Sub-region
13. Latin America Pulmonary Drug Delivery Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Product Type, 2023-2031
13.2.1. Dry Powder Inhalers
13.2.2. Metered Dose Inhalers
13.2.3. Nebulizers
13.3. Market Attractiveness, by Product Type
13.4. Market Value & Volume Forecast, by Application, 2023-2031
13.4.1. Asthma
13.4.2. COPD
13.4.3. Cystic Fibrosis
13.4.4. Others
13.5. Market Attractiveness, by Application
13.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
13.6.1. Retail Pharmacies
13.6.2. Hospital Pharmacies
13.6.3. E-Commerce
13.7. Market Attractiveness, by Distribution Channel
13.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031
13.8.1. Brazil
13.8.2. Mexico
13.8.3. Rest of Latin America
13.9. Market Attractiveness Analysis
13.9.1. By Product Type
13.9.2. By Application
13.9.3. By Distribution Channel
13.9.4. By Country/Sub-region
14. Middle East & Africa Pulmonary Drug Delivery Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value & Volume Forecast, by Product Type, 2023-2031
14.2.1. Dry Powder Inhalers
14.2.2. Metered Dose Inhalers
14.2.3. Nebulizers
14.3. Market Attractiveness, by Product Type
14.4. Market Value & Volume Forecast, by Application, 2023-2031
14.4.1. Asthma
14.4.2. COPD
14.4.3. Cystic Fibrosis
14.4.4. Others
14.5. Market Attractiveness, by Application
14.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
14.6.1. Retail Pharmacies
14.6.2. Hospital Pharmacies
14.6.3. E-Commerce
14.7. Market Attractiveness, by Distribution Channel
14.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031
14.8.1. GCC Countries
14.8.2. South Africa
14.8.3. Rest of Middle East & Africa
14.9. Market Attractiveness Analysis
14.9.1. By Product Type
14.9.2. By Application
14.9.3. By Distribution Channel
14.9.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. AstraZeneca Plc
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Type Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Novartis AG
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Type Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Boehringer Ingelheim GmbH
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Type Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. GlaxoSmithKline Plc
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Type Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Merck & Co., Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Type Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Teva Pharmaceutical Industries Ltd.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Type Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
List of Tables
Table 01: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
Table 02: Global Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
Table 03: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
Table 04: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2023-2031
Table 05: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Region, 2023-2031
Table 06: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country, 2023-2031
Table 07: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
Table 08: North America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
Table 09: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
Table 10: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2023-2031
Table 11: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
Table 12: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
Table 13: Europe Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
Table 14: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
Table 15: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel 2023-2031
Table 16: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
Table 17: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
Table 18: Asia Pacific Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
Table 19: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
Table 20: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2023-2031
Table 21: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
Table 22: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
Table 23: Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
Table 24: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
Table 25: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel 2023-2031
Table 26: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
Table 27: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
Table 28: Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
Table 29: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
Table 30: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel 2023-2031
List of Figures
Figure 01: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031
Figure 02: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 03: Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 04: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 05: Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application, 2023-2031
Figure 06: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 07: Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel 2023-2031
Figure 08: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Region, 2022 and 2031
Figure 09: Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Region, 2023-2031
Figure 10: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031
Figure 11: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 12: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 13: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 14: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application, 2023-2031
Figure 15: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 16: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel 2023-2031
Figure 17: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country, 2022 and 2031
Figure 18: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country, 2023-2031
Figure 19: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031
Figure 20: Europe Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 21: Europe America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 22: Europe Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 23: Europe Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application, 2023-2031
Figure 24: Europe Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 25: Europe Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel 2023-2031
Figure 26: Europe Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 27: Europe Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 28: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031
Figure 29: Asia Pacific Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 30: Asia Pacific America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 31: Asia Pacific Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 32: Asia Pacific Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application, 2023-2031
Figure 33: Asia Pacific Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 34: Asia Pacific Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel 2023-2031
Figure 35: Asia Pacific Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 36: Asia Pacific Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 37: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031
Figure 38: Latin America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 39: Latin America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 40: Latin America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 41: Latin America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application, 2023-2031
Figure 42: Latin America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 43: Latin America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 44: Latin America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 45: Latin America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 46: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031
Figure 47: Middle East & Africa America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2023-2031
Figure 48: Middle East & Africa America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 49: Middle East & Africa Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 50: Middle East & Africa Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel 2023-2031
Figure 51: Middle East & Africa Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 52: Middle East & Africa Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 53: Global Pulmonary Drug Delivery Devices Market Share Analysis, by Company (2022)